US FDA declines to approve Outlook Therapeutics' drug for eye condition-August 2024-www.financetom.com

US FDA declines to approve Outlook Therapeutics' drug for eye condition

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

US FDA declines to approve Outlook Therapeutics' drug for eye condition

Aug 28, 2025 3:58 AM

Aug 28 (Reuters) - The U.S. Food and Drug Administration

has declined to approve Outlook Therapeutics' ( OTLK )

experimental drug to treat a type of eye condition that causes

blurred vision, the company said on Thursday.

Previous page： Nice Faces Risk From Generative AI, Cloud-Based Services, Oppenheimer Says Next page： Warner Bros Discovery's gaming unit chief to step down after 12 years, memo shows

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Nice Faces Risk From Generative AI, Cloud-Based Services, Oppenheimer Says

Jan 23, 2025

12:25 PM EST, 01/23/2025 (MT Newswires) -- Nice (NICE) faces aggressive new competition as the contact center-as-a-service industry gets disrupted by generative artificial intelligence and cloud-based solutions, Oppenheimer said in a note Thursday. Analysts, including Timothy Horan, said that the industry is generally healthy, but the biggest challenge for Nice and the sector is that major cloud service providers are...

Warner Bros Discovery's gaming unit chief to step down after 12 years, memo shows

Jan 23, 2025

(Reuters) - Warner Bros Discovery's ( WBD ) gaming unit head David Haddad is leaving the company after 12 years in the role, according to an internal memo seen by Reuters on Thursday. Haddad, the president of Warner Bros Games, will stay on for the next three months as the company looks for his replacement, said JB Perrette, president of...

Update: AST SpaceMobile Shares Sink After Pricing of $400 Million Debt Offering

Jan 23, 2025

12:27 PM EST, 01/23/2025 (MT Newswires) -- (Updates with stock price movement in the headline and first paragraph) AST SpaceMobile ( ASTS ) shares sank by more than 14% in recent Thursday trading after the company priced a $400 million debt offering. The company priced $400 million of 4.25% convertible senior unsecured notes due 2032 in a private offering. Initial...

What's Going On With Nano Nuclear Energy Shares Thursday?

Jan 23, 2025

Nano Nuclear Energy, Inc. ( NNE ) stock is trading higher on Thursday after the company announced that it acquired a portfolio of patents. What To Know: The portfolio of patents, acquired from Ultra Safe Nuclear Corp, includes a United States patent titled “Modular Transportable Nuclear Generator,” as well as related patents issued in Canada, Russia, Korea and China. The...